A rare look at a private medical cannabis firm

You are receiving this as part of your free subscription to Strategic Tech Investor. To remove your email from this list, [unsubscribe here](. [Strategic Tech Investor] [CRITICAL: New Technology Is Sweeping the Country by Storm]( An esteemed group of scientists calls it "one of the greatest scientific achievements of all time." A federal mandate will send 7.1 million of these small devices across the U.S. in the coming months. And one tiny public company controls [107 patents for this device](. --------------------------------------------------------------- March 16, 2019 A Rare Look at a Private Medical Cannabis Firm By Michael A. Robinson Dear Strategic Tech Investor Reader, LATEST REPORT --------------------------------------------------------------- LATEST APPEARANCE --------------------------------------------------------------- [Is Facebook Heading for All-Time Highs?]( MICHAEL'S LATEST ALERTS --------------------------------------------------------------- Research [The $19 Billion Reasons Facebook Is Jumping into Crypto]( Trading [This Cancer Screener Should Hand Us Yet Another Round of Profits]( Cannabidiol (CBD) products are everywhere these days. And for cannabis investors, the future here looks very bright indeed. Particularly now that last year's Farm Bill legalized hemp, cannabis' non-psychoactive cousin that's one of the main sources of CBD, people have begun to try it out for a spin in a variety of products. A recent poll taken by New York-based investment bank Cowen & Co. of 2,500 people found that about 7% said they'd used CBD as a supplement in some fashion. That's a fairly large percentage for this relatively new product. As Cowen's Vivien Azer recently told Forbes: "I think it's because for some consumers, it actually works as both an anti-inflammatory and anti-anxiety [product]. Those are characteristics that are tangible to the consumers. With CBD, you know if it works for you or not. There is a tangible payback in relatively short order." Now, while the Food and Drug Administration (FDA) has approved GW Pharmaceuticals' ( :GWPH) anti-seizure drug Epidiolex - which uses CBD oil derived from the cannabis plant - it has yet to deem the substance safe as a food additive. That's why you might have seen places like New York City announcing CBD couldn't be sold from restaurants, bars and other venues yet. But don't expect that CBD ban to last for long - I fully anticipate the FDA, which has decided CBD is safe to use as a drug, and the cannabis industry will come to an agreement about the use of CBD as a supplement. As I said, for cannabis investors, that represents a huge potential upside. Cowen believes the CBD consumer products market tallied up to $2 billion in sales last year. By 2025, that figure should rise to $16 billion. Now, I've been tracking the cannabis industry since California legalized it for medical use in 1996. And as a board member with the National Institute for Cannabis Investors (NICI), I've seen my share of privately held cannabis companies reach out to us for advice on how to grow their business - including firms that focus on CBD. Here's the thing. Many of these outfits don't have a chance of making it in this highly competitive and capital-intensive space. But every now and then, we come across a firm with the skills and the product that can make a big impact - the sort that could be the next $1 billion company. In this unusual case, a firm that could be the next $52 billion company... See, this small cannabis startup is working on what could be one of the biggest medical breakthroughs of our lifetime. Even better, right now, for the first time, we can show you how to join the elite 0.1% of investors who get a chance to purchase a direct stake in a private company. [Click here for details on our first private cannabis venture](. Cheers and good investing, Michael A. Robinson Here's what else I'm following... --------------------------------------------------------------- [This Is a $12.3 TRILLION Opportunity]( In ordinary towns all across America, [these innovative devices]( are popping up and changing everything. There's $12 TRILLION in new wealth expected to be unleashed... and [this $6 stock]( could be better positioned than any other to skyrocket. [All the details are here](. Wall Street's Worst "Nightmare" Is the Key to Your Retirement Success Almost everybody is in a different stage when it comes to saving for retirement. But whether you just started, have been for a while, or are in the golden years of your retirement, there is the same fear across the board - running out of money. Wall Street feeds off of this fear, preaching that you have to depend on social security or other financial instruments under their control. But here's the thing... there's a way to make enough money for retirement that you never have to worry about running out. And Tom Gentile is telling you exactly how to do that in his twice-weekly Power Profit Trades. [Click here]( to learn his secret now. [These Tiny Defense Companies Could Lead Us Straight to an American Victory]( China's latest power play was aimed clearly at 1600 Pennsylvania Avenue. But the Pentagon has $1.7 trillion locked and loaded - and it's ready to circle its target as early as tomorrow. [Some tiny defense companies]( could receive billions of dollars in funding to take down China... and if you put a few dollars down now, you could be riding this wave of victory all the way to the bank. [Take a look - before the rest of the world catches up](. [America's Tech Sweetheart]( Drone technology is rapidly expanding. With the rise of high-definition cameras, sophisticated chips, and smart-controls, drones are becoming more accessible - [and it may not be for the best](. YOU MAY HAVE MISSED... --------------------------------------------------------------- [If you're looking for a reason to learn about crypto, here are three]( [Shocking footage: This guy isn't your typical stock market millionaire]( [Start right here to see how to turn $500 into $1 million (faster than you ever thought possible)]( [Married or divorced? Don't fall down this retirement hole...]( --------------------------------------------------------------- [Facebook]( [Twitter]( [More...]( mailto:?subject=Michael%20Robinson's%20Strategic%20Tech%20Investor&body=Check%20out%20http%3A%2F%2Fwww.strategictechinvestor.com%2F You are receiving this e-mail at, {EMAIL}, as a part of your free subscription to Strategic Tech Investor. Remove your email from this list: [Unsubscribe]( [Manage Your Email Preferences]( To cancel by mail or for any other subscription issues, write us at: Strategic Tech Investor | Attn: Member Services | 1125 N Charles Street | Baltimore, MD 21201 North America: 888.384.8339; International: 443.353.4519; Fax: 410.622.3050 [Contact Customer Service]( Website: [( © 2019 Strategic Tech Investor All Rights Reserved. Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of: Strategic Tech Investor. 1125 N Charles Street, Baltimore MD 21201.